lncRNA Oip5-as1 inhibits excessive mitochondrial fission in myocardial ischemia/reperfusion injury by modulating DRP1 phosphorylation

• Published in: Cellular & molecular biology letters Vol. 29; no. 1; pp. 72 - 38
• Main Authors: Niu, Xiaowei, Zhang, Jingjing, Hu, Shuwen, Dang, Wenhui, Wang, Kaiwen, Bai, Ming
• Format: Journal Article
• Language: English
• Published: England BioMed Central 14-05-2024; BMC
• Subjects: AKAP1; Animals; Apoptosis; Calcineurin; Cardiomyocytes; Cardiovascular disease; Cell death; Cell Line; Cholecystokinin; Coronary artery; CRISPR; Dephosphorylation; Dynamins - genetics; Dynamins - metabolism; Flow cytometry; Genome editing; Genomes; Heart; Hypoxia; Immunofluorescence; Immunoprecipitation; Ischemia; Kinases; Long non-coding RNAs; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Dynamics - genetics; Mitochondrial fission; Molecular modelling; Myocardial infarction; Myocardial ischemia; Myocardial ischemia/reperfusion injury; Myocardial Reperfusion Injury - genetics; Myocardial Reperfusion Injury - metabolism; Myocardial Reperfusion Injury - pathology; Myocardium; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; Non-coding RNA; Oip5-as1; Oxidative stress; Phosphorylation; Physiology; Proteins; Reperfusion; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Therapeutic targets; Transmission electron microscopy; Vectors; Western blotting; United States > US; China; Long non-coding RNAs; Calcineurin; Oip5-as1; Mitochondrial fission; Myocardial ischemia/reperfusion injury; AKAP1; DRP1
• ISSN: 1689-1392; 1425-8153; 1689-1392
• DOI: 10.1186/s11658-024-00588-4

Aberrant mitochondrial fission, a critical pathological event underlying myocardial ischemia/reperfusion (MI/R) injury, has emerged as a potential therapeutic target. The long non-coding RNA (lncRNA) Oip5-as1 is increasingly recognized for its regulatory roles, particularly in MI/R injury. However, its precise mechanistic role in modulating mitochondrial dynamics remains elusive. This study aims to elucidate the mechanistic role of Oip5-as1 in regulating mitochondrial fission and evaluate its therapeutic potential against MI/R injury.
To simulate in vitro MI/R injury, HL-1 cardiomyocytes were subjected to hypoxia/reoxygenation (H/R). Lentiviral vectors were employed to achieve overexpression or knockdown of Oip5-as1 in HL-1 cells by expressing Oip5-as1 or shRNA targeting Oip5-as1, respectively. The impact of Oip5-as1 on mitochondrial dynamics in HL-1 cells was assessed using CCK-8 assay, flow cytometry, immunofluorescence staining, and biochemical assays. MI/R injury was induced in mice by ligating the left anterior descending coronary artery. Conditional knockout mice for Oip5-as1 were generated using the CRISPR/Cas9 genome editing technology, while overexpression of Oip5-as1 in mice was achieved via intramyocardial administration of AAV9 vectors. In mice, the role of Oip5-as1 was evaluated through echocardiographic assessment, histopathological staining, and transmission electron microscopy. Furthermore, Western blotting, RNA pull-down, RNA immunoprecipitation, and co-immunoprecipitation assays were conducted to investigate Oip5-as1's underlying mechanisms.
The expression levels of Oip5-as1 are significantly decreased in MI/R-injured HL-1 cells and myocardium. In HL-1 cells undergoing H/R injury, overexpression of Oip5-as1 attenuated excessive mitochondrial fission, preserved mitochondrial functionality, and reduced cellular apoptosis, while knockdown of Oip5-as1 exhibited the opposite effects. Furthermore, in a mouse model of MI/R injury, overexpression of Oip5-as1 diminished mitochondrial fission, myocardial infarct size and improved cardiac function. However, knockout of Oip5-as1 exacerbated myocardial injury and cardiac dysfunction, which were significantly reversed by treatment with a mitochondrial division inhibitor-1 (Mdivi-1). Mechanistically, Oip5-as1 selectively interacts with AKAP1 and CaN proteins, inhibiting CaN activation and subsequent DRP1 dephosphorylation at Ser637, thereby constraining DRP1's translocation to the mitochondria and its involvement in mitochondrial fission.
Our study underscores the pivotal role of Oip5-as1 in mitigating excessive mitochondrial fission during MI/R injury. The findings not only enhance our comprehension of the molecular mechanisms underlying MI/R injury but also identify Oip5-as1 as a potential therapeutic target for ameliorating MI/R injury.